HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity.

Abstract
Type IB topoisomerases (Top1Bs) relax excessive DNA supercoiling associated with replication and transcription by catalyzing a transient nick in one strand to permit controlled rotation of the DNA about the intact strand. The natural compound camptothecin (CPT) and the cancer chemotherapeutics derived from it, irinotecan and topotecan, are highly specific inhibitors of human nuclear Top1B (nTop1). Previous work on vaccinia Top1B led to an elegant model that describes a straightforward dependence of rotation and religation on the torque caused by supercoiling. Here, we used a single-molecule DNA supercoil relaxation assay to measure the torque dependence of nTop1 and its inhibition by CPT. For comparison, we also examined mitochondrial Top1B and an N-terminal deletion mutant of nTop1. Despite substantial sequence homology in their core domains, nTop1 and mitochondrial Top1B exhibit dramatic differences in sensitivity to torque and CPT, with the N-terminal deletion mutant of nTop1 showing intermediate characteristics. In particular, nTop1 displays nearly torque-independent religation probability, distinguishing it from other Top1B enzymes studied to date. Kinetic modeling reveals a hitherto unobserved torque-independent transition linking the DNA rotation and religation phases of the enzymatic cycle. The parameters of this transition determine the torque sensitivity of religation and the efficiency of CPT binding. This "kinetic clutch" mechanism explains the molecular basis of CPT sensitivity and more generally provides a framework with which to interpret Top1B activity and inhibition.
AuthorsYeonee Seol, Hongliang Zhang, Yves Pommier, Keir C Neuman
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 109 Issue 40 Pg. 16125-30 (Oct 02 2012) ISSN: 1091-6490 [Electronic] United States
PMID22991469 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • DNA, Superhelical
  • Topoisomerase I Inhibitors
  • DNA Topoisomerases, Type I
  • TOP1 protein, human
  • Camptothecin
Topics
  • Base Sequence
  • Biomechanical Phenomena
  • Biophysics
  • Camptothecin
  • Cell Nucleus (metabolism)
  • DNA Replication (physiology)
  • DNA Topoisomerases, Type I (metabolism)
  • DNA, Superhelical (metabolism)
  • Humans
  • Mitochondria (metabolism)
  • Models, Biological
  • Nucleic Acid Conformation
  • Rotation
  • Sequence Homology
  • Topoisomerase I Inhibitors
  • Torque
  • Transcription, Genetic (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: